Cargando…

Development and psychometric validation of the REFlective evaLuation of psoriasis Efficacy of Treatment and Severity (REFLETS) questionnaire: a common measure of plaque-type psoriasis severity and treatment efficacy for patients and clinicians

BACKGROUND: To date, there is no global consensus on the definition of the severity of psoriasis. The REFlective evaLuation of psoriasis Efficacy of Treatment and Severity (REFLETS) questionnaire has recently been developed to provide a better understanding of plaque-type psoriasis severity and trea...

Descripción completa

Detalles Bibliográficos
Autores principales: Gilet, H, Roborel de Climens, A, Arnould, B, Bachelez, H, Bagot, M, Beaulieu, P, Joly, P, Jullien, D, Le Maître, M, Ortonne, JP, Paul, C, Thibout, E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BlackWell Publishing Ltd 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4359024/
https://www.ncbi.nlm.nih.gov/pubmed/25059687
http://dx.doi.org/10.1111/jdv.12601
_version_ 1782361330941952000
author Gilet, H
Roborel de Climens, A
Arnould, B
Bachelez, H
Bagot, M
Beaulieu, P
Joly, P
Jullien, D
Le Maître, M
Ortonne, JP
Paul, C
Thibout, E
author_facet Gilet, H
Roborel de Climens, A
Arnould, B
Bachelez, H
Bagot, M
Beaulieu, P
Joly, P
Jullien, D
Le Maître, M
Ortonne, JP
Paul, C
Thibout, E
author_sort Gilet, H
collection PubMed
description BACKGROUND: To date, there is no global consensus on the definition of the severity of psoriasis. The REFlective evaLuation of psoriasis Efficacy of Treatment and Severity (REFLETS) questionnaire has recently been developed to provide a better understanding of plaque-type psoriasis severity and treatment efficacy from both patient and clinician perspectives. OBJECTIVE: This study aimed to develop and psychometrically validate the new REFLETS questionnaire to evaluate patient and clinician perceptions of plaque-type psoriasis severity and treatment efficacy. METHODS: Two similar versions of the REFLETS questionnaire were developed following a rigorous methodology for clinicians and patients, referring to ‘the psoriasis of your patient' or to ‘your psoriasis’, respectively. An observational, longitudinal, multicentre study was conducted in France with 34 dermatologists and 430 mild to severe plaque-type psoriasis patients to finalize the questionnaire and evaluate its psychometric properties. RESULTS: Two dimensions were defined – severity and treatment efficacy – with three subdimensions within severity (impact of psoriasis, symptoms and disease course), and two individual items on joint pain. The questionnaire was well accepted by clinicians and patients. Excellent internal consistency (Cronbach's alpha = 0.66–0.98) and test–retest reliability (intraclass correlation coefficients = 0.83–0.94) were demonstrated. REFLETS scores were moderately to highly correlated to Psoriasis Area and Severity Index (r = 0.35–0.70), Skindex-29 (r = 0.46–0.82) and DLQI scores (r = 0.36–0.82). Patients with decreased psoriasis severity and those with increased treatment efficacy, according to patient global evaluations, had lower severity and higher treatment efficacy REFLETS scores, respectively. CONCLUSION: REFlective evaLuation of psoriasis Efficacy of Treatment and Severity is a promising tool for assessing plaque-type psoriasis severity and treatment efficacy from patient and clinician perspectives. It may help to improve patient and clinician communication in treatment decision making.
format Online
Article
Text
id pubmed-4359024
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BlackWell Publishing Ltd
record_format MEDLINE/PubMed
spelling pubmed-43590242015-03-19 Development and psychometric validation of the REFlective evaLuation of psoriasis Efficacy of Treatment and Severity (REFLETS) questionnaire: a common measure of plaque-type psoriasis severity and treatment efficacy for patients and clinicians Gilet, H Roborel de Climens, A Arnould, B Bachelez, H Bagot, M Beaulieu, P Joly, P Jullien, D Le Maître, M Ortonne, JP Paul, C Thibout, E J Eur Acad Dermatol Venereol Original Articles BACKGROUND: To date, there is no global consensus on the definition of the severity of psoriasis. The REFlective evaLuation of psoriasis Efficacy of Treatment and Severity (REFLETS) questionnaire has recently been developed to provide a better understanding of plaque-type psoriasis severity and treatment efficacy from both patient and clinician perspectives. OBJECTIVE: This study aimed to develop and psychometrically validate the new REFLETS questionnaire to evaluate patient and clinician perceptions of plaque-type psoriasis severity and treatment efficacy. METHODS: Two similar versions of the REFLETS questionnaire were developed following a rigorous methodology for clinicians and patients, referring to ‘the psoriasis of your patient' or to ‘your psoriasis’, respectively. An observational, longitudinal, multicentre study was conducted in France with 34 dermatologists and 430 mild to severe plaque-type psoriasis patients to finalize the questionnaire and evaluate its psychometric properties. RESULTS: Two dimensions were defined – severity and treatment efficacy – with three subdimensions within severity (impact of psoriasis, symptoms and disease course), and two individual items on joint pain. The questionnaire was well accepted by clinicians and patients. Excellent internal consistency (Cronbach's alpha = 0.66–0.98) and test–retest reliability (intraclass correlation coefficients = 0.83–0.94) were demonstrated. REFLETS scores were moderately to highly correlated to Psoriasis Area and Severity Index (r = 0.35–0.70), Skindex-29 (r = 0.46–0.82) and DLQI scores (r = 0.36–0.82). Patients with decreased psoriasis severity and those with increased treatment efficacy, according to patient global evaluations, had lower severity and higher treatment efficacy REFLETS scores, respectively. CONCLUSION: REFlective evaLuation of psoriasis Efficacy of Treatment and Severity is a promising tool for assessing plaque-type psoriasis severity and treatment efficacy from patient and clinician perspectives. It may help to improve patient and clinician communication in treatment decision making. BlackWell Publishing Ltd 2015-03 2014-07-25 /pmc/articles/PMC4359024/ /pubmed/25059687 http://dx.doi.org/10.1111/jdv.12601 Text en © 2014 The Authors. Journal of the European Academy of Dermatology and Venereology published by John Wiley & Sons Ltd on behalf of the European Academy of Dermatology and Venereology. http://creativecommons.org/licenses/by-nc-nd/3.0/ This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
spellingShingle Original Articles
Gilet, H
Roborel de Climens, A
Arnould, B
Bachelez, H
Bagot, M
Beaulieu, P
Joly, P
Jullien, D
Le Maître, M
Ortonne, JP
Paul, C
Thibout, E
Development and psychometric validation of the REFlective evaLuation of psoriasis Efficacy of Treatment and Severity (REFLETS) questionnaire: a common measure of plaque-type psoriasis severity and treatment efficacy for patients and clinicians
title Development and psychometric validation of the REFlective evaLuation of psoriasis Efficacy of Treatment and Severity (REFLETS) questionnaire: a common measure of plaque-type psoriasis severity and treatment efficacy for patients and clinicians
title_full Development and psychometric validation of the REFlective evaLuation of psoriasis Efficacy of Treatment and Severity (REFLETS) questionnaire: a common measure of plaque-type psoriasis severity and treatment efficacy for patients and clinicians
title_fullStr Development and psychometric validation of the REFlective evaLuation of psoriasis Efficacy of Treatment and Severity (REFLETS) questionnaire: a common measure of plaque-type psoriasis severity and treatment efficacy for patients and clinicians
title_full_unstemmed Development and psychometric validation of the REFlective evaLuation of psoriasis Efficacy of Treatment and Severity (REFLETS) questionnaire: a common measure of plaque-type psoriasis severity and treatment efficacy for patients and clinicians
title_short Development and psychometric validation of the REFlective evaLuation of psoriasis Efficacy of Treatment and Severity (REFLETS) questionnaire: a common measure of plaque-type psoriasis severity and treatment efficacy for patients and clinicians
title_sort development and psychometric validation of the reflective evaluation of psoriasis efficacy of treatment and severity (reflets) questionnaire: a common measure of plaque-type psoriasis severity and treatment efficacy for patients and clinicians
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4359024/
https://www.ncbi.nlm.nih.gov/pubmed/25059687
http://dx.doi.org/10.1111/jdv.12601
work_keys_str_mv AT gileth developmentandpsychometricvalidationofthereflectiveevaluationofpsoriasisefficacyoftreatmentandseverityrefletsquestionnaireacommonmeasureofplaquetypepsoriasisseverityandtreatmentefficacyforpatientsandclinicians
AT roboreldeclimensa developmentandpsychometricvalidationofthereflectiveevaluationofpsoriasisefficacyoftreatmentandseverityrefletsquestionnaireacommonmeasureofplaquetypepsoriasisseverityandtreatmentefficacyforpatientsandclinicians
AT arnouldb developmentandpsychometricvalidationofthereflectiveevaluationofpsoriasisefficacyoftreatmentandseverityrefletsquestionnaireacommonmeasureofplaquetypepsoriasisseverityandtreatmentefficacyforpatientsandclinicians
AT bachelezh developmentandpsychometricvalidationofthereflectiveevaluationofpsoriasisefficacyoftreatmentandseverityrefletsquestionnaireacommonmeasureofplaquetypepsoriasisseverityandtreatmentefficacyforpatientsandclinicians
AT bagotm developmentandpsychometricvalidationofthereflectiveevaluationofpsoriasisefficacyoftreatmentandseverityrefletsquestionnaireacommonmeasureofplaquetypepsoriasisseverityandtreatmentefficacyforpatientsandclinicians
AT beaulieup developmentandpsychometricvalidationofthereflectiveevaluationofpsoriasisefficacyoftreatmentandseverityrefletsquestionnaireacommonmeasureofplaquetypepsoriasisseverityandtreatmentefficacyforpatientsandclinicians
AT jolyp developmentandpsychometricvalidationofthereflectiveevaluationofpsoriasisefficacyoftreatmentandseverityrefletsquestionnaireacommonmeasureofplaquetypepsoriasisseverityandtreatmentefficacyforpatientsandclinicians
AT julliend developmentandpsychometricvalidationofthereflectiveevaluationofpsoriasisefficacyoftreatmentandseverityrefletsquestionnaireacommonmeasureofplaquetypepsoriasisseverityandtreatmentefficacyforpatientsandclinicians
AT lemaitrem developmentandpsychometricvalidationofthereflectiveevaluationofpsoriasisefficacyoftreatmentandseverityrefletsquestionnaireacommonmeasureofplaquetypepsoriasisseverityandtreatmentefficacyforpatientsandclinicians
AT ortonnejp developmentandpsychometricvalidationofthereflectiveevaluationofpsoriasisefficacyoftreatmentandseverityrefletsquestionnaireacommonmeasureofplaquetypepsoriasisseverityandtreatmentefficacyforpatientsandclinicians
AT paulc developmentandpsychometricvalidationofthereflectiveevaluationofpsoriasisefficacyoftreatmentandseverityrefletsquestionnaireacommonmeasureofplaquetypepsoriasisseverityandtreatmentefficacyforpatientsandclinicians
AT thiboute developmentandpsychometricvalidationofthereflectiveevaluationofpsoriasisefficacyoftreatmentandseverityrefletsquestionnaireacommonmeasureofplaquetypepsoriasisseverityandtreatmentefficacyforpatientsandclinicians